New York- Presbyterian Hospital
Learning to overcome fear is difficult for teens, brain study finds
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by ...
Psychology & Psychiatry
Sep 27, 2012 |
4.2 / 5 (5) |
8
|
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain
Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
Medical research
Jun 27, 2012 |
5 / 5 (7) |
7
|
Researchers reveal crucial immune fighter role of the STING protein
Researchers at Weill Cornell Medical College have unlocked the structure of a key protein that, when sensing certain viruses and bacteria, triggers the body's immediate immune response.
Medical research
Jun 18, 2012 |
5 / 5 (4) |
0
|
Distinct molecular subtype of prostate cancer identified
A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical ...
Genetics
May 20, 2012 |
5 / 5 (1) |
0
|
Two genetic deletions in human genome linked to aggressive prostate cancer development
An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer. The findings, published ...
Cancer
Apr 09, 2012 |
5 / 5 (1) |
0
|
New powerful tool measures metabolites in living cells
By engineering cells to express a modified RNA called "Spinach," researchers have imaged small-molecule metabolites in living cells and observed how their levels change over time. Metabolites are the products of individual ...
Medical research
Mar 08, 2012 |
5 / 5 (1) |
0
|
Researchers clock the speed of brain signals
Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of ...
Neuroscience
Jun 22, 2011 |
4.4 / 5 (14) |
4
|
Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Mass spectrometry helps researchers 'watch' how antibiotics attack tuberculosis bacteria inside cells
Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside ...
Medical research
Nov 01, 2012 |
not rated yet |
0
|
New definition of autism in DSM-5 will not exclude most children with autism, new study says
Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers ...
Autism spectrum disorders
Oct 02, 2012 |
4.8 / 5 (4) |
1
|
Double drug combo could shut down abnormal blood vessel growth that feeds disease
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic ...
Medical research
Sep 10, 2012 |
5 / 5 (2) |
0
|
Stopping and starting cancer cell cycle weakens and defeats multiple myeloma
Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then ...
Cancer
Jun 21, 2012 |
5 / 5 (1) |
0
|
Hidden vitamin in milk yields remarkable health benefits
A novel form of vitamin B3 found in milk in small quantities produces remarkable health benefits in mice when high doses are administered, according to a new study conducted by researchers at Weill Cornell Medical College ...
Medical research
Jun 14, 2012 |
4.8 / 5 (6) |
0
|
